Streetbeat News

Stock Prices

AMRN

Sarissa Capital has publicly stated that they believe Amarin Corporation's stock (AMRN) is significantly undervalued. Sarissa Capital, which is a long-term shareholder of Amarin, has been buying more shares at the current low prices. Details of their recent share purchases will be disclosed in an upcoming 13D filing.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 9:25 pm

AEY

ADDvantage Technologies Group, Inc. (NASDAQ:AEY) has regained compliance with Nasdaq's minimum bid price requirement after its stock closed at $1.00 or higher for 10 consecutive business days. The company had previously been notified of non-compliance due to its stock price falling below $1.00 for 30 consecutive business days.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 9:23 pm

CJET

Chijet reported a significant decline in revenues for the six months ended June 30, with a 73.2% drop to $2.6M compared to the previous year. The company also saw a 71.8% decrease in the units of vehicles sold, down to 309 units.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 9:21 pm

AMC

CVNA

GME

TUP

GameStop Corporation (NYSE:GME) shares have surged nearly 50% since last Tuesday, sparking speculation of another meme stock rally. Other meme stocks like Carvana Co. (NYSE:CVNA), Tupperware Brands Corporation (NYSE:TUP), and AMC Entertainment Holdings, Inc. (NYSE:AMC) are also on the rise. Despite a pullback last Thursday, GME shares rebounded on Monday, trending on Yahoo Finance with a nearly 14% increase. Investors are anticipating GameStop's third-quarter earnings report on Dec. 6, with an expected quarterly loss of eight cents per share and revenue of $1.18 billion.

Portfolio Pulse from Ryan Gustafson

December 04, 2023 | 9:21 pm

ALT

HRTS

LLY

NVO

PFE

Pharmaceutical companies are racing to develop obesity treatments, with Novo Nordisk and Eli Lilly seeing significant share price increases due to their obesity drugs. Pfizer's development setback has led to a share price decline, while Altimmune's successful drug tests boosted its shares. Roche acquired Carmot Therapeutics to enter the obesity drug market. The Tema Cardiovascular and Metabolics ETF (HRTS) was launched to track the performance of weight loss drugs and their producers.

Portfolio Pulse from Neil Dennis

December 04, 2023 | 9:20 pm

CULP

Culp, Inc. (NYSE:CULP) reported Q2 earnings with an EPS of $-0.19, beating estimates by 13.64% and surpassing the expected $-0.22. Revenue increased by $344 thousand compared to the same period last year. Despite beating EPS estimates last quarter, CULP's share price fell by 1.58% the following day. Historical earnings data shows a trend of Culp beating revenue and EPS estimates in recent quarters.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 9:20 pm

AAMC

Altisource Asset Management Corporation (AAMC) received a notice from the NYSE on November 30, 2023, indicating that AAMC's common stock will be delisted due to non-compliance with listing standards. AAMC intends to appeal the decision within the required seven-day period. The outcome of the appeal is uncertain, and further announcements will be made post-appeal regarding the stock's listing status.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 9:19 pm

HOOD

In November 2023, Robinhood Markets Inc. saw a significant increase in customer activity, with approximately $1.4 billion in net deposits and a 75% increase in crypto notional trading volumes compared to October 2023, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 9:19 pm

NXTP

NextPlay Technologies received a notice from Nasdaq for non-compliance with listing rules. The company intends to appeal and has paid for the appeal request, believing it can regain compliance before the hearing.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 9:18 pm

SOFO

Sonic Foundry, Inc. (NASDAQ:SOFO) received a final delisting notice from Nasdaq due to non-compliance with the minimum bid price and stockholders' equity requirements. Trading of SOFO's common stock on Nasdaq will be suspended from December 5, 2023, and the company will begin trading on the OTC Markets Group platform under the same symbol. Despite the delisting, CEO Joe Mozden, Jr. remains focused on growth and the development of new businesses like Global Learning Exchange™ and Vidable®.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 9:18 pm